Search

Kanmin Xue

Retinal Vascularization Rate Predicts Retinopathy of Prematurity and Remains Unaffected by Low-Dose Bevacizumab Treatment
Ranked importance of visual function outcome measures in choroideremia clinical trials
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity

Published with Wowchemy — the free, open source website builder that empowers creators.